Current reports
8-K
Submission of Matters to a Vote of Security Holders
5 Jun 24
8-K
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
13 May 24
8-K
Departure of Directors or Certain Officers
16 Apr 24
8-K
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
21 Mar 24
8-K
Regulation FD Disclosure
5 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
25 Jul 23
Registration and prospectus
S-8
Registration of securities for employees
13 May 24
S-8
Registration of securities for employees
25 Jul 23
424B4
Prospectus supplement with pricing info
21 Jul 23
S-1MEF
Registration of additional securities for an S-1
20 Jul 23
8-A12B
Registration of securities on exchange
17 Jul 23
S-1/A
IPO registration (amended)
17 Jul 23
S-1/A
IPO registration (amended)
23 Jun 23
S-1
IPO registration
12 Jun 23
DRS
Draft registration statement
15 May 23
D
$80M in equity, sold $80M, 23 investors
14 Jul 21
Other
EFFECT
Notice of effectiveness
21 Jul 23
CERT
Certification of approval for exchange listing
20 Jul 23
CORRESP
Correspondence with SEC
18 Jul 23
CORRESP
Correspondence with SEC
18 Jul 23
CORRESP
Correspondence with SEC
5 Jul 23
CORRESP
Correspondence with SEC
23 Jun 23
UPLOAD
Letter from SEC
22 Jun 23
CORRESP
Correspondence with SEC
21 Jun 23
CORRESP
Correspondence with SEC
12 Jun 23
UPLOAD
Letter from SEC
12 Jun 23
Ownership